Monitoring tissue coagulation during thermoablative treatment by using a novel magnetic resonance imaging contrast agent

Investigative Radiology

Volumn 39, Issue 11, 2004, Pages 661-665

  Vogel, Mika W ^a   Entius, Cornelius A C ^a   Pattynama, Peter M T ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Animals; Lasers; Magnetic resonance; MR contrast media; MR thermometry

Indexed keywords

BIOLOGICAL MARKER; GADOFOSVESET; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; HEMODYNAMIC MONITORING; LASER SURGERY; MUSCLE TISSUE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANK SUM TEST; SWINE; VALIDATION PROCESS;

EID: 7044263033     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200411000-00003     Document Type: Article

References (20)

1. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787-800.
2. Hindman JC. Proton resonance shift of water in gas and liquid states. J Chem Phys. 1966;44:4582-4592.
3. Parker DL, Smith V, Sheldon P, et al. Temperature distribution measurements in two-dimensional NMR imaging. Med Phys. 1983;10:321-325.
4. Bottomley PA, Foster TH, Argersinger RE, et al. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1-100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys. 1984;11:425-448.
5. Pushek T, Farahani K, Saxton RE, et al. Dynamic MRI-guided interstitial laser therapy: a new technique for minimally invasive surgery. Laryngoscope. 1995;105:1245-1252.
6. Mueller-Lisse UG, Heuck AF, Thoma M, et al. Predictability of the size of laser-induced lesions in T1-Weighted MR images obtained during interstitial laser-induced thermotherapy of benign prostatic hyperplasia. J Magn Reson Imaging. 1998;8:31-39.
7. Dick EA, Wragg P, Joarder R, et al. Feasibility of abdomino-pelvic T1-weighted real-time thermal mapping of laser ablation. J Magn Reson Imaging. 2003;17:197-205.
8. Lauffer RB, Dunham SO. Contrast-enhanced diagnostic imaging method for monitoring interventional therapies. Patent Cooperation Treaty. International Patent WO 99/17809: Epix Medical Inc; 1999.
9. Mahfouz AE. Ms-325 Epix. Curr Opin Invest Drugs. 2000;1:476-480.
10. Lauffer RB, Parmelee DJ, Dunham SU, et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology. 1998;207:529-538.
11. Stuber M, Botnar RM, Danias PG, et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging. 1999;10:790-799.
12. Prasad PV, Cannillo J, Chavez DR, et al. First-pass renal perfusion imaging using MS-325, an albumin-targeted MRI contrast agent. Invest Radiol. 1999;34:566-571.
13. Lahti KM, Lauffer RB, Chan T, et al. Magnetic resonance angiography at 0.3 T using MS-325. Magma. 2001;12:88-91.
14. Corot C, Violas X, Robert P, et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol. 2003;38:311-319.
15. Herborn CU, Waldschuetz R, Lauenstein TC, et al. Contrast-enhanced magnetic resonance imaging (MS-325) in a murine model of systemic lupus erythematosus. Invest Radiol. 2002;37:464-469.
16. Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol. 1997;32:741-747.
17. Hynynen K, Darkazanli A, Damianou CA, et al. The usefulness of a contrast agent and gradient-recalled acquisition in a steady-state imaging sequence for magnetic resonance imaging-guided noninvasive ultrasound surgery. Invest Radiol. 1994;29:897-903.
18. Kahn T, Harth T, Bettag M, et al. Preliminary experience with the application of gadolinium-DTPA before MR imaging-guided laser-induced interstitial thermotherapy of brain tumors. J Magn Reson Imaging. 1997;7:226-229.
19. Fossheim SL, Il'yasov KA, Hennig J, et al. Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. Acad Radiol. 2000;7:1107-1115.
20. McDannold N, Fossheim SL, Rasmussen H, et al. Heat-activated liposomal MR contrast agent: initial in vivo results in rabbit liver and kidney. Radiology. 2004;230:743-752.